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Time trends in late onset sepsis and meningitis in Very Low Birth Weight infants from 2000 to 
2013: Results from a Portuguese tertiary level Neonatal Intensive Care Unit 
 
 
Abstract 
 
Objective: To assess the evolution of the prevalence of late onset sepsis and meningitis and its 
predictors in a Portuguese tertiary level Neonatal Intensive Care Unit (NICU) during the 
participation in the Vermont Oxford Network (VON) between 2000 and 2013. 
Methods: Descriptive retrospective study of all Very Low Birth Weight infants admitted to level- 
III NICU between 2000 and 2013. Outborn infants, infants who died in the delivery room and 
neonates who died during the first 12 hours in NICU were excluded. Patients’ demographic 
characteristics and clinical data were collected. Data from neonates with and without late onset 
sepsis were compared. 
Results: The prevalence of late onset sepsis significantly decreased from 56.3% between 2000 and 
2004 to 26.5% between 2010 and 2013. Infants with a gestational age of 22-27 weeks had more 
late onset sepsis (LOS) (65.6%) than neonates with 32-36 weeks (20.9%). Similarly, smaller infants 
(weighing ≤ 1000g) had more LOS (59.4%) than babies with a weight > 1000g (33.3%). Late 
onset sepsis was significantly associated with a gestational age between 22 and 27 weeks, 
mechanical ventilation, nasal CPAP, necrotizing enterocolitis and the use of steroids for 
bronchopulmonary dysplasia. 
Conclusions: Preterm infants require many invasive devices to ensure their survival, namely 
mechanical ventilation, which greatly increases their infection risk. To minimize this risk, it is 
crucial to guarantee that better practices of asepsis are followed, being necessary to carry out 
regular audits. It is really important to know the data about late onset sepsis of our NICU, which 
allows sharing and comparison with peers in order to improve nosocomial infection prevention 
and control practices. 
Keywords: Late onset sepsis; VLBW infants; Neonatal Intensive Care Unit; nosocomial infection; 
preterm infants; VON database 
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Introduction 
 
During the last years, there was a significant decrease in childhood mortality worldwide. 
However, the decrease in neonatal mortality occurred at much lower rates, considering that in 
1990, 37.4% of under-5 deaths were due to neonatal mortality and in 2013, that percentage was 
41.6% [1]. 
The third leading cause of neonatal mortality happens to be neonatal sepsis, only behind preterm 
birth complications and intrapartum-related complications. Of all deaths in children under the age 
of 5 registered in 2010, 64.0% were attributable to infectious causes and 40.3% occurred in 
neonates [2]. 
Although there were advances in neonatal care which improved survival and reduced 
complications in preterm infants, sepsis continues to be a major cause of mortality and morbidity 
among Very Low Birth Weight (VLBW, those who weigh less than 1500g) infants in Neonatal 
Intensive Care Units (NICU) [3,4]. 
Apart from the mortality caused by neonatal sepsis, late onset sepsis significantly influences late 
neurodevelopment at the corrected age of 2 years old in premature infants with VLBW, being the 
gram-positive bacteria associated with a motor deficit. At a follow-up for up to 24 months of 
corrected age, among VLBW preterm infants with late onset sepsis, 6.1% of neonates had severe 
neurodevelopmental impairment and 3.2% of infants had cerebral palsy [5,6]. 
All around the world, there are neonates who are affected by sepsis, which happens more 
frequently with premature and low birth weight (LBW) infants [7–9]. 
Infants in NICUs all around the world (6.3 in 1000 admissions), mainly preterm and LBW 
neonates, are affected by sepsis. A study found a LOS cumulative incidence of 6.3 episodes per 
1000 NICU admissions [7]. The incidence of LOS considerably varies from centre to centre, 
ranging from 10.6% to 31.7% [8]. 
Fungal sepsis is less common than bacterial sepsis (incidence between 0.3% to 6.7%), however, 
it results in great mortality and morbidity [9]. Benjamin et al. found that 73% of extremely low 
birth weight (ELBW) infants who developed candidiasis ended up dead or having some 
neurodevelopment impairment [10]. 
In a study performed in this NICU, they found 549 (13.9%) patients with clinical or confirmed 
sepsis between 2003 and 2012. Fifteen of which (2.7%) had confirmed fungal sepsis on blood 
cultures and all of them had low birth weight (LBW), 13 (86.7%) had VLBW and 9 (60%) had 
extremely low birth weight (ELBW) [9]. 
From all live births, VLBW neonates take up a percentage of 1.5% of live births. Nonetheless, 
they account for more than 50% of infant deaths in the United States [11]. 
The association between birth weight and mortality is among the strongest in epidemiology. A 
mortality of at least 100-fold higher than those with an optimal weight (the weight associated with 
the lowest mortality) is found in neonates weighing less than 1500 g [12]. 
Over the last four decades, it was possible to observe an improvement on neonatal survival, 
particularly in the developed countries which have witnessed an increasing survival of extremely 
low birth weight infants during this period [13]. 
Nevertheless, and contributing to their special vulnerability to nosocomial infections, preterm and 
VLBW infants are particularly immature regarding their immune system [14]. 
Preterm birth was found to be the major risk factor for neonatal sepsis, given that the risk of 
infection among premature neonates is 11 times greater than among full term infants. Premature 
neonates’ skin and mucous barriers are immature, and they possess underdeveloped defence 
mechanisms against infection. The risk of developing neonatal sepsis is inversely proportional to 
birth weight and gestational age [5]. 
Appropriately, preterm newborns with late onset sepsis (LOS) had lower birth weight and 
gestational age, worse perinatal conditions and higher severity scores on the first day of life. 
Within hospitalization, they had higher morbidity and invasive devices were used more frequently 
when compared with infants without infection [15]. 
Central line-associated bloodstream infections (CLASBI) are caused by indwelling intravascular 
central-lines (IICL) in 1-20% of hospitalized newborns, which represents an important and 
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preventable cause of nosocomial sepsis. Beside IICL, there are other risk factors for nosocomial 
infections that increase the burden of late onset sepsis. These risk factors include long-term use of 
other invasive interventions, such as mechanical ventilation and parenteral nutrition, skin sores, 
prolonged hospitalization stay, surgeries and underlying respiratory and cardiovascular diseases. 
Consequently, preventive strategies should be adopted in NICU to reduce colonization [5,14,16]. 
Since the central lines are one of the leading causes of nosocomial infections, a study was 
performed in this NICU and Soares et al. showed that infectious complications occurred in 20% 
patients (CLASBI rate of 12.4/1000 catheter days). Of the 51 (12.8%) CLASBI episodes, a 
positive blood culture was obtained in 35 (68.6% of infected central lines). As expected, preterm 
birth was a risk factor for indwelling complication [17]. 
It is important to implement some measures to prevent nosocomial infections, since they decrease 
the incidence density of nosocomial sepsis, as we concluded with a study in this NICU that showed 
that the incidence density of nosocomial sepsis decreased significantly from 8.6 to 4.8 per 1000 
days (44%) after a new preventive bundle implementation [14]. 
Freitas et al. showed that newborns who developed late onset sepsis were more exposed to 
invasive procedures, including the use of mechanical ventilation (MV) and peripherally inserted 
central catheters (PICC). They found that there was an association between the use of mechanical 
ventilation for 10 or more days and late onset sepsis in 80.8% of cases, while PICCs left in place 
for 11 days or longer were associated with LOS in 76.2% of cases [18]. 
The technique and scientific evolution of Neonatology during the years allowed the reduction of 
the viability threshold and a bigger survival with less morbidity [19]. 
In fact, as the incidence of LOS increased, the survival of premature infants consequently 
followed, especially in VLBW neonates. This indicates the role of hospitalization, invasive 
procedures and life-sustaining medical devices in the pathogenesis of neonatal LOS [4,20]. 
Therefore, the advance in neonatal intensive care medicine is a double-edged sword, in one hand 
causing improved survival of neonates, and in the other increased rate of LOS [16]. 
Coagulase-negative Staphylococcus represents the commonest microorganism that provokes LOS 
in developed countries, since it is responsible for 39-54% of episodes [21]. Gram-negative 
pathogens accounted for 18% of first episodes of LOS, being Escherichia coli, Klebsiella sp, 
Pseudomonas aeruginosa, Enterobacter sp and Serratia sp the most frequent Gram-negative 
bacteria. Finally, fungal microorganisms caused 12% of all first episode infections, with Candida 
albicans being the third most common isolated microorganism (6%) [8]. Comparatively, late onset 
pathogens tend to be more resistant to monotherapy antibiotic regimens than early onset ones 
[21,22]. 
Meningitis remains a frequent presentation of late onset group B streptococcal (GBS) disease and 
despite reduced mortality, it continues to entail a significant morbidity among GBS survivors, 
who present serious neurologic sequelae and permanent impairment [3,23]. It is more common in 
the first month of life than in any other age group. Its nonspecific clinical presentation, 
indistinguishable from that caused by sepsis, especially late onset sepsis, makes it difficult but 
imperative to identify [24]. In developing countries, neonatal meningitis is present in 0.8-6.1 per 
1000 live births [21]. 
As one of the largest neonatal databases, the Vermont Oxford Network (VON) collects and 
maintains data about VLBW infants and neonates who fulfil other eligibility requirements from 
many parts of the world since 1989 [25]. 
Newborns are eligible for the VLBW database if they are born with a weight between 401 and 
1500g, or with a gestational age between 22 and 29 weeks, and if they are born at the member 
hospital or are transferred to it within 28 days of birth. Neonates born at a participating hospital 
whose deaths happened in the delivery room or before NICU admission are included [26]. 
Currently, VON includes more than 1200 centres around the world that voluntarily submit data 
about the care and outcomes of high risk newborns. The VON databases have the primary goal of 
assisting member hospitals in understanding their performance for purposes of quality 
improvement [26,27]. 
VON serves as a neutral, independent party in analysing data for their member centres and 
facilitating voluntary benchmarking activities [28]. 
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VON has sponsored many quality improvement collaboratives that have improved both treatment 
practice and outcomes [29]. 
Besides VON, there is a National Registration of Very Low Birth Weight Newborns in Portugal, 
which was founded in 1994 and was composed by 13 NICUs. The data from this little sample 
allows us to identify the main problems of these Portuguese infants and to assess how each unit 
works. From 1996, the registration was extended to a new NICU and to 18 special care units [30]. 
In this registration, between 1994 and 1996, they found sepsis as one of the most frequent 
pathologies (34%) and with an incidence significantly higher when compared with VON (26%). 
Regardless of the cause of death, sepsis was one of the most frequent diseases found in dead 
VLBW infants (38%) [30]. 
The collection of the prospective data on infections episodes from NICUs by these neonatal 
infection surveillance programmes has the aim of monitoring the changes in the epidemiology of 
pathogens and their antibiotic resistance over time. This information is important to benchmark 
clinical practice, inform policy and improve quality of care [31,32]. 
A more complete picture of the epidemiology of neonatal infections is provided by multicentre 
studies, which show greater scope for the development of successful interventions [31]. 
Rates of LOS and hospital-acquired bloodstream infections (HABSIs) provide vital information 
regarding the success of hospital guidelines concerning infection control procedures, such as hand 
hygiene, cot separation and central line care [31]. 
To improve our understanding of the epidemiology and create quality improvement programmes, 
neonatal infection surveillance programmes represent a valuable tool. Their aim is to reduce 
infection rates and effectively prevent the development of resistance [31]. 
Neonatal infection surveillance networks serve several purposes, like knowing about LOS 
incidence and its variability, comparing results with those of other networks and proposing public 
health policies to improve neonatal care quality and safety [15,33]. 
This study aims to assess the evolution of the prevalence of late onset sepsis and meningitis and 
its predictors in the NICU of Centro Hospitalar Universitário de São João during the participation 
in the Vermont Oxford Network (VON) between 2000 and 2013. 
 
Methods 
 
The data were collected from the VON in which Neonatal Intensive Care Unit (NICU) of Centro 
Hospitalar Universitário de São João participated from 2000 to 2013 with the registration of all 
inborn and outborn VLBW infants (any infant who is born alive at our hospital and whose birth 
weight is between 401 and 1500 grams or whose gestational age is between 22 weeks 0 days and 
29 weeks 6 days and any outborn infant who is admitted to our hospital within 28 days of birth, 
without first having gone home, and whose birth weight is between 401 and 1500 grams or whose 
gestational age is between 22 weeks 0 days and 29 weeks 6 days). 
We collected data about infants who had late onset sepsis and meningitis from the files we 
registered on VON during these 13 years. Demographic and clinical data of VLBW infants who 
had late onset sepsis and meningitis admitted to our NICU in that period were analysed. 
Definitions for demographic and clinical data were provided in the “Manual of Operations: Part 
2” by the VON. 
 
Demographic data 
 
We registered the gender (female or male), the gestational age in weeks and days and birth weight 
in grams, location of birth – inborn, if the infant was delivered at our centre and outborn if the 
infant was delivered outside our centre. 
Multiple gestation, if two or more live foetuses were documented at any time during the 
pregnancy, which resulted in the birth of the infant and mode of delivery (C-section or vaginal 
delivery) were registered. 
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Clinical data 
 
Clinical data collected in delivery room were Apgar score and neonatal resuscitation, including 
nasal CPAP (Continuous Positive Airway Pressure). In NICU, we registered data of conventional 
ventilation and oxygen therapy. 
It was reported that newborns received steroids for chronic lung disease (CLD) if systemic 
corticosteroids were used after birth to treat or prevent bronchopulmonary dysplasia or chronic 
lung disease. 
For the diagnosis of Patent Ductus Arteriosus (PDA), at least one of the following findings needs 
to be present: left to right or bidirectional ductal shunt on Doppler echo, systolic or continuous 
murmur and at least two of the following findings are present: hyperdynamic precordium, 
bounding pulses, wide pulse pressure, pulmonary vascular congestion, cardiomegaly or both. 
Indomethacin was administered after birth for treatment of PDA and Ibuprofen for the prevention 
or treatment of PDA. 
The neonates with severe retinopathy of prematurity (ROP) were identified. Severe ROP is 
defined by: stage 2- presence of intraretinal ridge; stage 3- presence of a ridge with extraretinal 
fibrovascular proliferation; stage 4- partial retinal detachment; stage 5- total retinal detachment. 
If infants had necrotizing enterocolitis (NEC), diagnosed prior to initial disposition, and/or 
following readmission after initial transfer without being discharged home, they were referred as 
NEC carriers. The following clinical and radiographical criteria were used: at least one of the 
following clinical signs must be present – bilious gastric aspirate or emesis, abdominal distension, 
occult or gross blood in stool (no fissure) and at least one of the following radiographic findings 
must be present – pneumatosis intestinalis, hepatobiliary gas, pneumoperitoneum. 
According to the development of sepsis on or before day 3, children were categorized as having 
early onset sepsis if a bacterial pathogen, coagulase-negative staphylococcal or fungal was 
recovered from a blood and/or cerebrospinal fluid culture obtained on day 1, 2 or 3 of life. 
On the other hand, individuals were classified as having late onset sepsis and/or meningitis, if a 
bacterial pathogen, coagulase-negative staphylococcal or fungal was recovered from a blood 
and/or cerebral spinal fluid culture obtained after day 3 of life at our hospital prior to initial 
disposition. 
Respiratory distress syndrome (RDS) is defined as PaO2 < 50 mmHg in room air, central cyanosis 
in room air, a requirement for supplemental oxygen to maintain PaO2 > 50 mmHg, or a requirement 
for supplemental oxygen to maintain a pulse oximeter saturation over 85% within the first 24 
hours of life and a chest radiograph consistent with RDS (reticulogranular appearance to lung 
fields with or without low lung volumes and air bronchograms) within the first 24 hours of life. 
Children were marked as having severe Periventricular-Intraventricular Haemorrhage (PIH) when 
they had PIH grade 3 (intraventricular blood, ventricular dilation) or PIH grade 4 
(intraparenchymal haemorrhage) at our hospital prior to initial disposition or following 
readmission after initial transfer without being discharged home. 
Likewise, infants with Cystic Periventricular Leukomalacia (CPVL) were referred like that when 
they had evidence of cystic periventricular leukomalacia on a cranial ultrasound, computed 
tomography, or magnetic resonance imaging scan obtained at any time. 
The major birth defects found in this sample include tracheoesophageal fistula, oesophageal 
atresia, obstructive uropathy with congenital hydronephrosis, pulmonary atresia with ventricular 
septal defect, interrupted aortic arch, double outlet right ventricle, duodenal atresia, omphalocele, 
pulmonary stenosis, trisomy 21, tetralogy of Fallot with or without pulmonary atresia, trisomy 13, 
cleft palate, gastroschisis, congenital hydrocephalus, Prader Willi (SALSA MLPA Kit P245- A2), 
pulmonary atresia with intact ventricular septum and complete atrioventricular canal. 
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Study sample definition 
 
At the beginning of the study, 607 babies were identified, from which 95 outborn infants were 
excluded. Then, 6 infants died in the delivery room, so, at that point, there were 506 infants. 18 of 
these infants died during the first 12 hours in NICU. Finally, 55 infants had missing information on 
outcome. The final sample for the study was 433 infants (Figure 1). 
 
Statistical analysis 
 
The statistical analysis was performed using SPSS® for Windows®, version 25. Categorical 
variables were characterized by absolute and relative frequencies. Chi-Square or Fisher’s exact 
test were used to compare categorical variables with Bonferroni’s correction on pairwise 
comparisons. 
A multivariate analysis by logistic regression was performed to evaluate predictive factors for late 
onset sepsis. The strength of the association was measured by Odds Ratio (OR) and 95% 
confidence intervals (95% CI). Only variables that presented significance up to 0.05 and those 
clinically relevant in the univariate analysis were included in the model. A p-value less than 0.05 
was considered statistically significant. To create the most parsimonious model, variables that did 
not reach significance level of p-value < 0.05 in the multivariable model were backward 
eliminated one by one. 
The Ethics Committee of Centro Hospitalar Universitário de São João approved this study. 
 
 
Results 
 
Demographic characteristics of study population (Table 1) 
 
Our population was composed by 221 female infants (51.0%) and 212 male newborns (49.0%). 
Most of the infants were born between 28 and 31 weeks of gestation (230, 53.1%). Furthermore, 
93 newborns were born between 22 and 27 weeks of gestation (21.5%) and 110 between 32 and 
36 weeks (25.4%). 
At birth, 160 neonates weighed 1000 grams or less (37.0%) and there were 273 babies whose 
weight was greater than 1000g (63.0%). 
In relation to the number of foetuses found in pregnancies, 287 (66.3%) were gestations with only 
one foetus and were documented two or more foetuses during 146 (33.7%) pregnancies. 
Regarding the type of delivery, 314 neonates were born by C-section (72.5%) and 119 babies were 
born by vaginal delivery (27.5%). 
Finally, an Apgar score at 5 minutes of less than 7 was registered in 58 newborns (13.4%), whereas 
375 infants had an Apgar score at 5 minutes equal or higher than 7 (86.6%). 
 
Late onset sepsis outcomes according to year of birth (Table 2) 
 
Between 2000 and 2013, 43% of the infants had at least one episode of late onset sepsis. The most 
frequent aetiology was coagulase-negative staphylococcal infection, since 34.2% of all infants had 
an infection caused by this microorganism. A total of 16.4% infants had other bacterial pathogen 
identified as the cause of LOS and only 3.2% had a fungal infection. 
From 2000 to 2004, 94 (56.3%) out of 167 infants had late onset sepsis. The most frequent 
aetiology of late onset sepsis between these years was coagulase-negative Staphylococcus (78 
infants, corresponding to 46.7% of the total 167 newborns), followed by other bacterial pathogens’ 
infections whose prevalence was 27.5% (46/167). Only 7 infants (4.2%) had late onset sepsis 
caused by fungi. 
Between 2005 and 2009, 61 out of 149 (40.9%) infants developed late onset sepsis. Once again, 
most of the infected children had coagulase-negative staphylococcal infection (33.6%, 50/149). 
On the other hand, 11 neonates had LOS caused by other bacteria (7.4%) and 6 babies had fungal 
infection (4.0%). 
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During the last years of this study (2010-2013), 31 out of 117 infants had late onset sepsis (26.5%). 
Among infected newborns, 20 had coagulase-negative staphylococcal LOS (17.1%), 14 
developed LOS provoked by other bacteria (12.0%) and 1 child had a fungal infection (0.9%). 
 
Late onset sepsis outcomes according to gestational age (Table 3) 
 
In the group of infants born between 22 and 27 weeks of gestation, 65.6% had late onset sepsis 
(61/93). Among infants with this range of gestational ages, 43 out of 93 (46.2%) had LOS caused 
by coagulase-negative Staphylococcus, 27 developed LOS from other bacteria (29,0%) and 8 had 
a fungal infection (8.6%). 
For infants born between 28 and 31 weeks of gestation, 102 out of 230 had late onset sepsis 
(44.3%). The most frequent aetiology was coagulase-negative Staphylococcus infection with a 
prevalence of 37.8% (87/230). Infections caused by other bacterial pathogens registered a 
prevalence of 16.5% (38/230) and by fungal organisms showed a prevalence of 1.7% (4/230). 
At last, newborns with a gestational age between 32 and 36 weeks registered a prevalence of LOS 
of 20.9% (23/110). 18 out of 110 neonates had a coagulase-negative staphylococcal infection, 
whose prevalence was 16.4%. Other bacterial infections showed a prevalence of 5.5%, since 6 out 
of 110 had infections caused by other bacteria apart from coagulase-negative Staphylococci. 
Fungal infections exhibited a prevalence of 1.8% (2/110). 
 
Late onset sepsis outcomes according to birth weight (Table 4) 
 
The group of infants born with a weight equal to or less than 1000g presented a prevalence of late 
onset sepsis of 59.4% (95/160). In this group, 70 out of 160 had coagulase-negative staphylococcal 
infection (43.8%), 28.9% had LOS caused by other bacteria (43/160) and 10 developed a fungal 
infection (6.2%). 
Differently, neonates whose birth weight was greater than 1000g had a prevalence of LOS of 
33.3% (91/273). Among these children, 78 had coagulase-negative staphylococcal infection 
(28.6%), 28 developed LOS provoked by other bacterial microorganisms (10.3%) and 4 had a 
fungal infection (1.5%). 
 
Univariate/comparative analysis of infants with and without late onset sepsis 
 
Relatively to the gender of the infants, there was no statistically significant difference in the 
prevalence of LOS between female and male infants (p-value = 0.990). 
There was no statistically significant difference in the prevalence of LOS in terms of type of 
delivery – C-section versus vaginal delivery (p-value = 0.087). Similarly, there was no statistically 
significant difference in LOS between neonates with Apgar score < 7 and ≥ 7 (p-value = 0.757). 
The majority of newborns who did not require mechanical ventilation did not develop LOS 
(74.9%), whereas neonates that needed ventilation had a prevalence of LOS of 54.1% (p-value = 
<0.001). 
Among infants who had respiratory distress syndrome (RDS), 50.2% had LOS, when compared 
with 34.7% of those who did not have RDS (p-value = 0.001). 
In the group of patients with necrotizing enterocolitis (NEC), 76.5% developed LOS, while only 
41.6% of the infants without NEC had LOS (p-value = 0.004). 
In the case of children with Patent Ductus Arteriosus (PDA), 61.1% of them had LOS, compared 
with 36.9% of those who did not have PDA (p-value <0.001). 
There was no statistically significant difference in the prevalence of LOS between individuals 
with neurologic morbidity or without it, given there was no statistically significant difference 
between infants with cystic periventricular leukomalacia (CPVL) and without CPVL (p-value = 
0.112) neither between neonates with intraventricular haemorrhage (IVH) ≥ III and without IVH 
≥ III (p-value = 0.478). 
The administration of steroids for bronchopulmonary dysplasia showed a statistically significant 
difference on the prevalence of LOS (82.6% of the infants that took steroids for 
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bronchopulmonary dysplasia (BPD) had LOS versus 40.7% of the newborns that did not take 
steroids for BPD) (p-value = <0.001). 
Of neonates who required nasal CPAP, 48.5% developed LOS versus 24.2% who did not use nasal 
CPAP (p-value = <0.001). 
There was no statistically significant difference between newborns who needed high frequency 
ventilation (HFV) and those who did not require HFV (p-value = 0.069). 
Among children who had retinopathy of prematurity (ROP) ≥ stage 2, 71.4% developed LOS 
compared with those without ROP ≥ stage 2, whose prevalence of LOS was 52.7% (p-value = 
0.037). 
Finally, there was no statistically significant difference in LOS between infants with and without 
major birth defects (p-value = 0.416). 
 
Predictor factors for late onset sepsis (Table 5) 
 
When the gestational age was analysed, we found an Odds Ratio (OR) of 3.348 for the group with 
gestational age between 22 and 27 weeks (95% CI, 1.544 – 7.263, p-value = 0.002) and an OR of 
1.533 for the group of infants born with a gestational age between 28 and 31 weeks (95% CI, 
0.830 – 2.834, p-value = 0.172). 
Regarding the use of mechanical ventilation, we found that neonates with conventional ventilation 
were 1.912 more likely to have LOS compared with others who did not require ventilation (95% 
CI, 1.138 – 3.210, p-value = 0.014). 
On the other hand, newborns who used nasal CPAP were 3.385 more likely to have LOS versus 
the ones who did not have to use nasal CPAP (95% CI, 1.849 – 6.197, p-value <0.001). 
In terms of necrotizing enterocolitis, newborns with NEC were 5.103 times more likely to develop 
LOS than those without NEC (95% CI, 1.534 – 16.970, p-value = 0.008). 
In this study, we found that infants who took steroids for bronchopulmonary dysplasia were 4.145 
times more likely to have LOS that those that did not take steroids for BPD (95% CI, 1.282 – 
13.398, p-value = 0.018). 
 
 
Discussion 
 
This study allowed us to draw conclusions about the evolution of the prevalence of late onset 
sepsis and meningitis during the years of participation (from 2000 to 2013) of Centro Hospitalar 
Universitário de São João in the VON. In addition, this study made possible to conclude which 
variables are the predictors of late onset sepsis. 
As expected, since it was verified in other studies, the prevalence of LOS from all causes 
significantly decreased (56.3% vs 26.5%, p-value < 0.001) between 2000-2004 and 2010-2013. 
Effectively, Bizzarro et al. reported that rates of late onset sepsis subsequently showed a 
significant decrease from 2004 to 2013 [34]. 
We verified that coagulase-negative Staphylococcus was the most frequent pathogen found as a 
causative of LOS in our NICU. In fact, coagulase-negative staphylococci have emerged as the 
predominant pathogens of LOS, accounting for 53.2%-77.9% of LOS in industrialised countries 
and 35.5%-47.4% in some developing regions [16]. 
The decline in the prevalence of coagulase-negative staphylococcal (46.7% vs 17.1%) and other 
bacterial infections (27.5% vs 12.0%) during the years of this study was statistically significative 
too (p-value < 0.001). Bizzarro and colleagues found that the prevalence of late onset sepsis rates 
attributed to coagulase-negative Staphylococcus decreased too [34]. 
In contrast, the prevalence of fungal infections did not suffer a statistically significant decrease 
(4.2% vs 0.9%, p-value = 0.229), probably because the incidence of fungal infections in this NICU 
is relatively low. Similarly, in a German study, only 4.3% of late onset sepsis episodes were caused 
by Candida spp. Gram-positive bacteria were documented in 77.4% of the cases, being coagulase-
negative staphylococci the most predominant pathogens (48.5%). 18.3% episodes were caused by 
gram-negative bacilli [35]. 
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These results make sense in the light of constantly improving infection prevention initiatives 
developed over the years. Indeed, we can infer that the improvement in outcomes relative to LOS 
was due to the improvement of asepsis practices and from what we have learned in comparison 
with the experience of other neonatal centres. 
Besides VON, there is a national registration of Very Low Birth Weight Newborns in Portugal 
that collects data about neonatal infection and it has also contributed to the decrease of nosocomial 
infection registered over the years. 
As mentioned before, the lower the gestational age, the higher the prevalence of late onset sepsis. 
Therefore, the incidence of LOS was higher in newborns with 22-27 weeks (65.6%) compared to 
the group of infants that were born with 28-31 weeks (44.3%) and the group of infants with 32- 
36 weeks (20.9%) (p-value < 0.001). These results are in agreement with other studies that reported 
higher incidence of LOS in neonates with less than 28 weeks (36.3% versus 29.6% with a 
gestational age of 29-32 weeks versus 17.5% in infants born with 33-36 weeks) [16]. In fact, a 
North American study showed similar tendencies between infants with different gestational ages. 
They reported an incidence of LOS of 20% in newborns with 28 weeks compared with 58% among 
newborns with a gestational age of 22 weeks [3]. 
Stoll et al. registered that, among infants who survived more than 3 days, 32% were diagnosed 
with late onset sepsis, with the percentage increasing with decreasing gestational age (28 weeks: 
20%, 22 weeks: 61%) [36]. 
As previously stated, VLBW infants are especially susceptible to nosocomial infections. 
Regarding birth weight, the group of infants with ≤ 1000g had more LOS (59.4%) than the 
neonates that were born with > 1000 g (33.3%) (p-value < 0.001). These results match with those 
of others that conclude that the incidence of LOS is especially high in preterm newborns, with a 
birth weight of less than 1500 grams [24]. In fact, low birth weight is the single most important 
variable in the predisposition for sepsis. The high incidence of sepsis in very low birth weight was 
confirmed in a study performed in our NICU, which found 28% of confirmed sepsis and 15% of 
probable sepsis [37]. 
Given that there are studies that reported that respiratory distress syndrome is a determinant factor 
for poor clinical outcome in neonatal sepsis [38], we analysed whether individuals with respiratory 
distress syndrome had more LOS than those without RDS and we found that the prevalence of 
LOS was statistically significantly higher in neonates with RDS (71.4% vs 52.7%, p-value = 
0.001). Similarly, Tewabe and colleagues found that newborns with a history of respiratory 
distress syndrome were 74.2% more likely to develop poor neonatal outcome [38]. 
Fehlmanna et al. reported that RDS was associated with an increased risk in the incidence of late 
onset sepsis. They found that, in neonates with less than 1500 g, RDS was associated 
independently and significantly with an increased risk of LOS [39]. 
Although it was not statistically significant in the multivariable model, in the univariate analysis, 
we found that children with Patent Ductus Arteriosus (PDA) had more LOS than neonates without 
PDA (61.1% vs 36.9%, p-value <0.001). This finding met the conclusions of another study 
conducted in Taiwan, in which they found that neonates with PDA had a relatively higher rate of 
recurrent sepsis than those without PDA (25.3% vs 15.2%, p-value = 0.079) [40]. 
As we expected based on other studies, a higher percentage of individuals with retinopathy of 
prematurity (ROP) ≥ stage 2 developed sepsis in relation to those without ROP ≥ stage 2 (71.4% 
vs 52.7%, p-value = 0.037). For example, Leviton et al. found that some of the disorders that occur 
preferentially in the extremely low gestational age neonates tend to occur together more 
commonly than expected if they were independent, which was most evident for severe NEC and 
LOS. Both occurred more often than expected in infants who had severe BPD and severe ROP 
[41]. 
A Portuguese study found that infants with a gestational age of less than 28 weeks had an OR of 
5.4 (95% IC, 3.1 – 9.4, p-value < 0.001) for infections associated with health care. They also 
concluded that for each additional week in gestational age the risk of infection associated with 
health care decreased by 20% [42]. When the gestational age was analysed, we found that infants 
with a gestational age between 22 and 27 weeks had a 3.348 (95% CI, 1.544 – 7.263, p-value = 
0.002) higher infection rate than neonates that were born with 32-36 weeks and infants born with 
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a gestational age between 28 and 31 weeks had a 1.533 (95% CI, 0.830 – 2.834, p-value = 0.172) 
higher infection rate than neonates that were born with 32-36 weeks. 
Neonates that required mechanical ventilation were 1.912 (95% CI, 1.138 – 3.210, p-value = 
0.014) more likely to have LOS compared with the ones who did not require mechanical 
ventilation. The use of mechanical ventilation (MV) was already recognized as a risk factor for 
LOS in other studies. One of those reported that in the LOS group, MV was used in 79.5% of the 
infants vs. 34.3% in the non-LOS group (p-value < 0.001) [43]. 
On the other hand, newborns who used nasal CPAP showed a 3.385 (95% CI, 1.849 – 6.197, p- 
value <0.001) higher prevalence of LOS compared with the infants who did not have to use nasal 
CPAP. However, a study conducted in South Korea suggested that aggressive early weaning from 
more invasive intubation and mechanical ventilation to less invasive assisted ventilation, such as 
nasal CPAP, is important to reduce the incidence of LOS in extremely preterm babies [44]. 
Another study conducted in Turkey demonstrated that the duration of mechanical ventilation was 
significantly long, and the duration of CPAP was not significant in the patients who died because 
of sepsis [45]. 
Since intestinal microbial overgrowth contributes to the development of necrotizing enterocolitis, 
it can be said that necrotizing enterocolitis is also an infection like LOS. Taking this issue into 
account, it was expected that newborns with NEC were 5.103 (95% CI, 1.534 – 16.970, p-value 
= 0.008) times more likely to develop LOS than those without NEC. Similarly, Kim et al. reported 
that neonates with NEC were 3.628 times more likely to have sepsis than those without NEC, 
especially in infants born with 23-24 weeks of gestation (95% CI, 1.332 – 9.883, p-value = 0.012) 
[44]. 
It is important to emphasize that the data collected in the VON database concerned individuals 
who took steroids for bronchopulmonary dysplasia, which may underestimate the prevalence of 
BPD in this population because steroids are only given in severe cases of BPD. 
We found that infants who took steroids for bronchopulmonary dysplasia had a 4.145 (95% CI, 
1.282 – 13.398, p-value = 0.018) higher infection rate than newborns that did not take steroids for 
BPD. 
In fact, considering that prolonged invasive mechanical ventilation increases the risk of 
bronchopulmonary dysplasia, neonates with BPD required mechanical ventilation for a longer 
period, which raises the risk of developing nosocomial infections. In addition, newborns with 
respiratory pathology are more likely to require intravenous support, a critical way of pathogen 
entry into the bloodstream [46]. 
Underlying secondary pulmonary hypertension (due to severe BPD) was significantly associated 
with higher risk of sepsis attributable mortality and BPD predisposed neonates to higher rates of 
ventilator associated pneumonia [47]. Moreover, late onset sepsis was found to be a risk factor for 
bronchopulmonary dysplasia [48]. 
 
 
Limitations of the study 
 
This study has the disadvantages inherent to a retrospective study. 
In addition, it might be interesting to analyse other data such as the presence of catheters, which 
was not registered in the VON database, or the duration of mechanical ventilation, which had 
missing values in most individuals. 
 
 
Study strengths 
 
This study was relevant to show the importance of participating in networks, such as VON, that 
allow benchmarking among the various neonatal centres in order to improve practices in the 
prevention and control of neonatal infection. 
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Conclusion 
 
During the time of the participation of our NICU in VON database, the prevalence of late onset 
sepsis significantly decreased from 56.3% between 2000 and 2004 to 26.5% between 2010 and 
2013. 
A gestational age between 22 and 27 weeks, mechanical ventilation, nasal CPAP, necrotizing 
enterocolitis and steroids for bronchopulmonary dysplasia were found to be statistically 
significant predictors of late onset sepsis. 
Sure enough, preterm infants require many invasive devices to ensure their survival, namely 
mechanical ventilation, which greatly increases their infectious risk. To minimize this risk, it is 
crucial to guarantee that better practices of asepsis are followed, being necessary to carry out 
regular audits. 
In conclusion, this study shows the importance of knowing the data about late onset sepsis of our 
NICU, which allows sharing and comparison with peers in order to improve nosocomial infection 
prevention and control practices. 
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Figures and tables 
Figure 1. Flowchart for study sample definition 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Excluded: 
95 outborn infants 
607 infants identified 
Excluded: 
6 deaths in delivery room 
433 infants 
Excluded: 
55 with missing 
information on outcome 
488 infants 
Excluded: 
18 deaths during the first 
12h in NICU 
506 infants 
512 infants 
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Table 1. Infants’ demographic characteristics 
 
Characteristic No. (%) of infants (n=433) 
Sex of the infant  
Female 221 (51.0%) 
Male 212 (49.0%) 
Gestational age (weeks)  
22-27 93 (21.5%) 
28-31 230 (53.1%) 
32-36 110 (25.4%) 
Birth weight (grams)  
≤ 1000 160 (37.0%) 
> 1000 273 (63.0%) 
Multiple gestation  
No 287 (66.3%) 
Yes 146 (33.7%) 
Mode of delivery  
C-section 314 (72.5%) 
Vaginal 119 (27.5%) 
Apgar Score at 5 minutes  
< 7 58 (13.4%) 
≥ 7 375 (86.6%) 
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Table 2. Infants who had at least one episode of LOS and meningitis according to year of birth 
 
Aetiology  Year of birth  p-value 
 2000-2004 
(n=167) 
2005-2009 
(n=149) 
2010-2013 
(n=117) 
Total 
(n=433) 
 
LOS from all 
causes, n (%) 
     
Yes 94 (56.3%)a 61 (40.9%)b 31 (26.5%)c 186 
(43.0%) 
<0.001* 
No 73 (43.7%)a 88 (59.1%)b 86 (73.5%)c 247 
(57.0%) 
 
Coagulase- 
negative 
staphylococcal 
infection, n (%) 
     
Yes 78 (46.7%)a 50 (33.6%)a 20 (17.1%)b 148 
(34.2%) 
<0.001* 
No 89 (53.3%)a 99 (66.4%)a 97 (82.9%)b 285 
(65.8%) 
 
Other bacterial 
pathogens, n (%) 
     
Yes 46 (27.5%)a 11 (7.4%)b 14 (12.0%)b 71 
(16.4%) 
<0.001* 
No 121 
(72.5%)a 
138 
(92.6%)b 
103 
(88.0%)b 
362 
(83.6%) 
 
Fungal infection, 
n (%) 
     
Yes 7 (4.2%) 6 (4.0%) 1 (0.9%) 14 
(3.2%) 
0.229† 
No 160 (95.8%) 143 (96.0%) 116 (99.1%) 419 
  (96.8%)  
 
 
Note that different superscript letters indicate significant differences between years’ groups. 
*Chi-square test 
† Fisher’s exact test 
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Table 3. Late onset sepsis and meningitis according to gestational age 
Aetiology  Gestational age  p-value 
 22-27 
weeks 
(n=93) 
28-31 weeks 
(n=230) 
32-36 weeks 
(n=110) 
Total 
(n=433) 
 
LOS from all 
causes, n (%) 
     
Yes 61 (65.6%)a 102 (44.3%)b 23 (20.9%)c 186 
(43.0%) 
<0.001* 
No 32 (34.4%)a 128 (55.7%)b 87 (79.1%)c 247 
(57.0%) 
 
Coagulase- 
negative 
staphylococcal 
infection, n (%) 
     
Yes 43 (46.2%)a 87 (37.8%)a 18 (16.4%)b 148 
(34.2%) 
<0.001* 
No 50 (53.8%)a 143 (62.2%)a 92 (83.6%)b 285 
(65.8%) 
 
Other bacterial 
pathogens, 
n (%) 
     
Yes 27 (29,0%)a 38 (16.5%)b 6 (5.5%)c 71 
(16.4%) 
<0.001* 
No 66 (71.0%)a 192 (83.5%)b 104 (94.5%)c 362 
(83.6%) 
 
Fungal 
infection, n (%) 
     
Yes 8 (8.6%)a 4 (1.7%)b 2 (1.8%)a, b 14 
(3.2%) 
0.010† 
No 85 (91.4%)a 226 (98.3%)b 108 
(98.2%)a,b 
419 
(96.8%) 
 
 
Note that different superscript letters indicate significant differences between gestational age 
groups based on pairwise comparisons. 
*Chi-square test 
† Fisher’s exact test 
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Table 4. Late onset sepsis and meningitis according to birth weight 
 
Aetiology  Birth weight  p-value 
LOS from all 
causes, n (%) 
≤1000 g 
(n=160) 
>1000 g 
(n=273) 
Total 
(n=433) 
 
Yes 95 (59.4%)a 91 (33.3%)b 186 (43.0%) <0.001* 
No 65 (40.6%)a 182 (66.7%)b 247 (57.0%)  
Coagulase- 
negative 
staphylococcal 
infection, n (%) 
    
Yes 70 (43.8%)a 78 (28.6%)b 148 (34.2%) 0.001* 
No 90 (56.2%)a 195 (71.4%)b 285 (65.8%)  
Other bacterial 
pathogens, n (%) 
    
Yes 43 (26.9%)a 28 (10.3%)b 71 (16.4%) <0.001* 
No 117 (73.1%)a 245 (89.7%)b 362 (83.6%)  
Fungal infection, 
n (%) 
    
Yes 10 (6.2%)a 4 (1.5%)b 14 (3.2%) 0.007* 
No 150 (93.8%)a 269 (98.5%)b 419 (96.8%)  
 
Note that different superscript letters indicate significant differences between birth weight 
groups based on pairwise comparisons. 
*Chi-square test 
† Fisher’s exact test 
 
 
Table 5. Predictor factors for late onset sepsis 
 
Predictors OR 95% CI p-value 
Gestational age    
22-27 weeks 3.348 [1.544; 7.263] 0.002 
28-31 weeks 1.533 [0.830; 2.834] 0.172 
32-36 weeks Ref   
Conventional 
ventilation 
   
Without Ref   
With 1.912 [1.138; 3.210] 0.014 
Nasal CPAP    
Without Ref   
With 3.385 [1.849; 6.197] <0.001 
Necrotizing 
Enterocolitis 
   
Without Ref   
With 5.103 [1.534; 16.970] 0.008 
Steroids for 
Bronchopulmonary 
Dysplasia 
   
Without Ref   
With 4.145 [1.282; 13.398] 0.018 
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Videos, audios and 3D illustrations 
Starting from July 2014, we intend to accept also 3D illustrations, audios and videos (e.g., with 
slide presentations or demonstrations of clinical procedures) to integrate (as PDF-embedded 
multimedia) into each kind of article, and we are planning to start a new Video series, featuring 
the explanation of medical procedures. You are welcome to send your contributions for evaluation 
(see more here). 
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